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Background: Left atrial (LA) size is a prognostic marker in severe aortic stenosis (AS). We aimed to study the impact of transcatheter aortic valve 
implantation (TAVI) on LA size and recovery of LA phasic function (reservoir, conduit and pump).
methods: In a single-center retrospective cohort, LA function using biplane volumes and 2D speckle tracking imaging (STE) in 12 LA segments 
during sinus rhythm was assessed prior to and at midterm follow-up after TAVI.
results: 46 patients with severe AS were included (81 ± 6 yrs, aortic valve area 0.7 ± 0.2cm2, and EuroSCORE 19 ± 14%). At 5 ± 3 months post 
TAVI (Table), LA phasic volumes and emptying fractions showed minimal changes. However, STE detected modest improvement in LA reservoir and 
pump function. In the 12 patients with ejection fraction ≤ 55%, the recovery was more pronounced by both volume and STE-derived parameters. The 
13 patients who had early post TAVI atrial fibrillation (AF) had deterioration of total and active emptying fraction (from 49 to 46% in AF vs 52 to 57% 
in no AF and from 29 to 26% in AF vs 35 to 39% in no AF, respectively) and peak negative strain (from -9.4 to -7.6% in AF vs -9.8 to -13.2% in no AF) 
at follow-up (P<0.05).
conclusion: In high-risk TAVI candidates, AS was associated with severe LA dilatation. Intrinsic LA compliance and contractile properties by STE 
improved at midterm follow-up after TAVI. Patients with lower ejection fraction had a greater recovery of LA function. Development of post-TAVI AF is a 
marker for a more diseased LA.
Parameters of LA volumes and phasic functions before and after TAVI
Overall cohort (N=46) EF ≤ 55% subgroup (N=12)
Variables Before TAVI Post-TAVI P-value Before TAVI Post-TAVI P-value
LA volumes/BSA, mL/m2
V max 52±18 48±16 0.19 51±17 46±12 0.18
V min 26±12 23±13 0.17 29±12 19±5 0.05
V preA 38±15 35±15 0.25 39±14 32±4 0.07
LA reservoir function
Total emptying volume, mL/m2 26±11 25±9 0.49 22±9 27±12 0.04
Expansion index 124±69 139±82 0.36 87±44 150±80 0.07
Total emptying fraction, % 51±14 54±14 0.36 44±12 57±12 0.02
LA conduit function 
Passive emptying volume, mL/m2 14±7 14±7 0.75 12±6 15±9 0.24
Passive emptying fraction, % 28±12 29±11 0.54 23±9 29±11 0.14
LA pump function
Active emptying volume, mL/m2 12±7 11±6 0.90 11±6 12±4 0.34
Active emptying fraction, % 33±15 35±16 0.43 28±14 39±11 0.06
LA reservoir function
Peak positive strain rate (SR), s-1 0.90±0.34 1.11±0.45 0.002 0.67±0.19 1.06±0.28 0.002
Total strain, % 20.7±8.0 22.3±8.7 0.27 15.9±4.7 22.0±7.0 0.04
LA conduit function 
Peak positive strain, % 11.0±7.4 10.7±4.6 0.72 7.6±2.5 9.3±4.3 0.31
Peak negative SR (early), s-1 -0.51± 0.23 -0.59± 0.30 0.10 -0.42± 0.15 -0.56± 0.34 0.22
LA pump function
Peak negative strain, % -9.7±4.5 -11.7±6.2 0.08 -8.3±4.3 -12.7±5.7 0.09
Peak negative SR (late), s-1 -0.88± 0.44 -1.07± 0.74 0.25 -0.66± 0.30 -1.05± 0.58 0.14
